Skip to main content
. 2021 Mar 2;13(5):1051. doi: 10.3390/cancers13051051

Figure 2.

Figure 2

Biodistribution of [177Lu]Lu-NeoB on gastrin-releasing peptide receptor (GRPR) expressing tumor bearing mice. (A) Biodistributions were performed at 1 h, 4 h, 24 h, 48 h, 96 h, 168 h, and at 4 h when co-injected with an excess of unlabeled NeoB (4 h + block). (B) Time activity curve of [177Lu]Lu-NeoB in the tumor and pancreas. (C) Tumor-to-organ ratio from 1 h to 168 h. Data are represented as mean ± SD.